LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.017783
 29.19 27.76 861 1863 0.4621 0.7611
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 29.19 27.76 883 1863 0.4739 0.7685
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 29.19 27.76 98 1863 0.0526 0.2310
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 29.19 27.76 1177 1863 0.6317 0.8542
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 30.90 27.76 871 2032 0.4286 0.7443
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 30.90 27.76 888 2032 0.4369 0.7498
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 30.90 27.76 103 2032 0.0507 0.2358
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 30.90 27.76 1217 2032 0.5988 0.8411
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 32.60 27.76 831 2235 0.3717 0.7106
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 32.60 27.76 849 2235 0.3797 0.7164
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 32.60 27.76 116 2235 0.0519 0.2534
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 32.60 27.76 1183 2235 0.5291 0.8087
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 34.30 27.76 861 2449 0.3515 0.7013
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 34.30 27.76 885 2449 0.3613 0.7085
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 34.30 27.76 114 2449 0.0465 0.2443
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 34.30 27.76 1171 2449 0.4780 0.7842
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 36.01 27.76 910 2662 0.3417 0.6990
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 36.01 27.76 927 2662 0.3481 0.7038
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 36.01 27.76 120 2662 0.0451 0.2490
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 36.01 27.76 1216 2662 0.4566 0.7755
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 37.71 27.76 863 2877 0.2999 0.6708
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 37.71 27.76 881 2877 0.3062 0.6759
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 37.71 27.76 128 2877 0.0445 0.2564
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 37.71 27.76 1306 2877 0.4538 0.7774
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 39.41 27.76 923 3105 0.2972 0.6734
MN20160318_Q01
D08